Feasibility assessment on a prospective clinical research study predicts the real potential for participant enrolment.
It is critical that researchers conduct a thorough feasibility assessment of any prospective clinical research studies, for which we are approached by commercial industry partners. There are a great number of considerations that must be weighed up before making a determination as to whether a specific study offers realistic potential to enrol participants, in line with the sponsor company’s expectations. At the RMH, we are taking a highly sophisticated, robust, consistent and objective approach to this process, rather than accepting new studies after only a cursory, arbitrary or subjective review. Undertaking this critical appraisal will help ensure that we are in a position to meet or exceed our enrolment predictions.
The Office for Research has developed a novel Clinical Trial Recruitment Predictor Tool , which we encourage researchers to utilise before committing to undertaking any sponsored studies. The user-friendly tool has 12 criteria (weighted on importance) which should be assessed (each on a 10 point scale), to help inform and provide guidance on the accrual potential of a given study. It is not intended that the tool should be used in isolation to make any feasibility determination, but rather should complement the normal review process, to ensure that all relevant aspects have been given due consideration.